Showing results (1171-1180 of 1,861) with videos related to

Sort By:
Pageof 187
Zhonghua Yi Xue Za Zhi|June 12, 2022
[Value of indocyanine green fluorescence tracer in laparoscopic cholecystectomy for acute cholecystitis]X D Zhang, T Li, L Jin, et al.
Scandinavian Journal of Immunology|January 11, 2007
Murine dendritic cells modified with CXCL10 gene and tumour cell lysate mediate potent antitumour immune responses in miceB Li, Q Li, Q-L Zhao, et al.
Oncogene|May 24, 2011
Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewalX Fang, Y Cai, J Liu, et al.
Advances in Therapy|June 27, 2019
Assessing Patient Preferences for Treatment Decisions for New Direct Acting Antiviral (DAA) Therapies for Chronic Hepatitis C Virus InfectionsTania M Welzel, Min Yang, Gautam Sajeev, et al.
Current Medical Research and Opinion|June 18, 2009
Treatment patterns and symptom control in patients with GERD: US community-based surveyWilliam D Chey, Reema R Mody, Eric Q Wu, et al.
Dermatology (Basel, Switzerland)|November 27, 2009
Impact of adalimumab on symptoms of psoriatic arthritis in patients with moderate to severe psoriasis: a pooled analysis of randomized clinical trialsPhilip J Mease, James Signorovitch, Andrew P Yu, et al.
Zhonghua Bing Li Xue Za Zhi = Chinese Journal of Pathology|September 21, 2016
[Expression of epidermal growth factor receptor mutation specific antibodies in lung adenocarcinoma: evaluation of sensitivity, specificity and relationship to histologic subtypes]Y M Lai, Q Feng, Y Sun, et al.
Neuropathology and Applied Neurobiology|July 28, 2020
Significance of cytosolic cathepsin D in Alzheimer's disease pathology: Protective cellular effects of PLGA nanoparticles against β-amyloid-toxicityY Wang, Q Wu, B G Anand, et al.
Journal of Medical Economics|May 17, 2012
The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsAnnie Guérin, Eric Q Wu, Vamsi K Bollu, et al.
Journal of Managed Care Pharmacy : JMCP|September 28, 2011
Economic evaluation of denosumab compared with zoledronic acid in hormone-refractory prostate cancer patients with bone metastasesJipan Xie, Madhav Namjoshi, Eric Q Wu, et al.
Pageof 187